We have new Biopharma jobs in your area!

We have new Biopharma jobs in your area! Search Now!

FIND A JOB  |  JOB ALERTS  |  EMAIL PREFERENCES Looking for a new job? Job Seeker, Check out the new job opportunities in your area at BioSpace.com, the leading online community for industry news and careers for life science professionals. Whether you are actively searching for a new position, need a career change or are curious to see what other opportunities are available, let BioSpace help you find your new job. Make sure employers can find you! Did you know employers search over 50,000 resumes on BioSpace each month? Be sure to upload your resume to BioSpace and publish your credentials to a host of outstanding employers.    Top Biopharma Headlines Want to know what everyone's talking about in Biopharma today? Check out the most popular articles this week from BioSpace.com Mylan Inc. Pledges $500 Million for Ireland Expansion; to Add 500 New Jobs Sexual Side Effect Warnings Added to Merck & Co., Inc. (MRK) Drugs Optimer Pharmaceuticals, Inc. Strips Chairman of Title, Fires CFO and Another Exec Bristol-Myers Squibb Company-Gilead Sciences, Inc. Hep C Drug Data Leaks Takeda Pharmaceutical Co. Ltd. to Buy URL Pharma for $800 Million Upfront Merck & Co., Inc. to Pay Up to $1 Billion to Endocyte, Inc. for Experimental Cancer Drug AstraZeneca PLC CEO Defends Strategy Amid Shareholder Demands and Questions for Change STAY CONNECTED FACEBOOK TWITTER LINKED IN GOOGLE+ You have received this email because you registered at BioSpace. BioSpace regularly sends emails to active subscribers on behalf of our advertising partners or to promote our own products and services. If you would like to stop receiving all email communications from BioSpace, you can unsubscribe at any time by clicking here. BioSpace 6465 South Greenwood Plaza, Suite 400, Centennial, CO 80111, U.S. (888) BIOSPACE Subscribe to: Post Comments (Atom) Click and Post Blog Archive ▼  2012 (843) ►  August (101) ►  July (89) ►  June (96) ►  May (102) ▼  April (96) Astra CEO in Line for $65M Goodbye - Apr. 30, 2012 FDA Approves VIVUS' Faster-Than Viagra ED Drug - A... Hologic Snags Gen-Probe for $3.72B Cash - Apr. 30,... FDA OKs VIVUS' 15 Min. Viagra Rival; Warner Weighs... Novo to Boost US Workforce by 15 Pct. - Apr. 27, 2012 FDA Rejects Amgen's BLA for Xgeva - Apr. 27, 2012 FDA Panel Backs Cameron Health's Heart Device - Ap... Novo Goes on US Hiring Binge; Jazz Spends $650M Ca... Astra CEO Steps Down; Amgen to Create 100 Jobs - A... Takeda's Actos Successor Fails to Win FDA OK - Apr... HeartWare Soars as FDA Panel Backs Implantable Pum... Astra CEO Quits; Generics Giant Created as Watson ... 50+ Verbs That Define a Killer Resume - Apr. 26, 2012 Amgen Smacks Down $700M for Turkey Drugmaker - Apr... Sanofi's Lemtrada Beats Rebif in MS Face-off - Apr... Medtronic Unit to Create 200 Jobs; Accelr8 Nabs $3... Targacept Cuts 46 Pct. of Jobs; Amgen Makes $700 M... Shareholders Before Patients? -- Apr. 25, 2012 Merck Slashes 580 Jobs Amid Swiss HQs Shutdown - A... Novartis Pushes UK Hospitals to Use $1,000 Drug - ... Aptuit Science Day Heart Device Glitch Killed Pt: Boston Sci - Apr. 2... Merck KGaA Axes 580 Jobs - Apr. 24, 2012 We have new Biopharma jobs in your area! Amylin Soars as Potential Bidding War Begins - Apr... FDA Pushes Back Bowel Drug Review: Ironwood, Fores... CareFusion Sells Nicolet Biz for $58M Cash - Apr. ... Could Amylin be Next in Astra's Buying Spree? - Ap... Merck KGaA CEO: We Must Cut Jobs, Reduce Costs - A... Pt Death Forces Novartis to Stop Hep C Trial - Apr... FDA: Feds Seize Contaminated Ultrasound Gel - Apr.... Death Pushes Novartis to Halt Trial; Merck Will Sl... Gilead-Bristol's Hep C Drug Cured 88% Post-Therapy... Human Genome Spurns GSK's $2.6B Takeover Offer - A... FDA OKs Bayer's Glucose Monitoring System; SynGen ... HGSI Rejects GSK's $2.59B Bid; BAX to Bring 1,500 ... 3 Reasons to Ditch That Resume Objective - Apr. 19... Your Healthy News Mylan to Create 500 Jobs; Illumina Drops as Roche ... Abbott Shows Off Positive Ph3 Parkinson's Data - A... Roche Abandons $6.8B Illumina Bid - Apr. 18, 2012 Mylan to Add 500 New Jobs; Pfizer Nears $10B Deal ... Novo Nordisk Warns FDA of Biosimilar Concerns - Ap... AVEO on Hiring Rampage - Apr. 17, 2012 Shire Extends RegenMed Reach in $200M Pervasis Acq... Medtronic to Boost Safety Monitoring of Devices; V... AVEO Goes on a Hiring Spree; Pervia Closes Up Shop... Endocyte Could Snag $1B From Merck Dev. Pact - Apr... Baxter, Halozyme Fall as FDA Demands More HyQ Data... More J&J Implant Recalls in AU, NZ, UK; Ventus to ... Endocyte Surges on $1B Merck CA Deal - Apr. 16, 2012 Astra CEO to Step Up His Game - Apr. 13, 2012 Novartis' Gilenya Pt. Develops Rare Brain Disease ... Tornier to Consolidate Facilities; Inogen Nabs $20... Astra CEO Defends Strategy; Biopharma Spent $49.5B... Teva Mulls Halting Dev. of Brand Drugs - Apr. 12, ... Sexual Side Effect Warnings Added to Merck Drugs -... Quest Scores Philips' Head as New CEO - Apr. 12, 2012 Teva May Dilute R&D; Sex Concerns Linked to Merck ... 7 Deadly Interview Sins - Apr. 12, 2012 Abbott's RA Drug Set to be World's Top-Seller - Ap... UK Launches $286M Biotech Fund; Takeda Makes $800M... Corning Pays $730M for Becton Unit; HemCon Files f... Takeda Forks Over $800M for URL Pharma - Apr. 11, ... Icahn Piles Pressure on Amylin With Lawsuit - Apr.... VIVUS Sinks as FDA Delays Decision on Qnexa - Apr.... eResearch Technology to Go Private for $400M - Apr... This is 3D Cell Culture Icahn Sues Amylin to Push for Sale; Amgen Pays $31... Some AZN Investors Want New CEO; Optimer Fires 3 T... Bristol-Gilead Hep C Drug Data Leaks - Apr. 9, 2012 Sony Axes 10,000 Workers; FDA OKs Lilly's Amyvid -... Optimer Fires Chairman, 2 Other Top Execs - Apr. 9... Pfizer Cuts Employee Severance Packages - Apr. 6, ... Novartis Compound Spurs Cartilage in Arthritic Mic... Medtronic to Expand; FDA Recalls Thoratec Heart De... Fired Pfizer Staff Gets Benefits Shaft; BioCon to ... Spectrum to Spend $206M to Buy Out Allos - Apr. 5,... Spectrum Bladder CA Drug Flunks Phase 3 Trial - Ap... Covidien to Shell Out $346M for Oridion Systems - ... Spectrum Buys Allos as Bladder CA Trial Fails Ph3 ... Avoiding the Downfall of Your Resume in 7 Steps - ... Your Healthy News Icahn Blasts Amylin Board, Demands Immediate Sale ... Abbott Hep Drug 93 Pct. Effective in Ph2 Study - A... St Jude Pulls Older LV CRT Leads From Market; Bio-... April 25-26 in London: Your New Medical Device St... Icahn Lashes Out at Amylin; OvaScience Rakes in $3... GSK to Seek OK for Diabetes Drug as Data Impresses... Astra Forges $50M Antibody Deal With Amgen - Apr. ... Biomet Bids $280M for DePuy's Trauma Biz - Apr. 2,... Amgen, Astra Strike $50M Inflammatory Drug Pact - ... Forest Smacks Down $357M for J&J's BP Drug - Apr. ... Keryx, Aeterna Tank as CA Drug Fails Trial - Apr. ... Medtronic Pays $85M to End Shareholder Lawsuit - A... Forest Pays J&J $357M for Hypertension Drug Rights... ►  March (124) ►  February (119) ►  January (116) ►  2011 (773) ►  December (106) ►  November (113) ►  October (116) ►  September (123) ►  August (129) ►  July (111) ►  June (75)